Conjunctivitis Drugs Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025- Poor hygienic conditions and low awareness among people of developing and underdeveloped countries about conjunctivitis boosting the market growth.
Conjunctivitis Drugs Market is expected to grow with a CAGR of 2.81% over the forecast period.
Scope of Global Conjunctivitis Drugs Market Report–
The conjunctivitis is an eye related disease especially found and spreads in children. Conjunctiva is a layer of tissues which is transparent and lines the inner surface of the eyelid and covers white part of the eye which becomes red or pink and get swollen in conjunctivitis. It can be caused by bacteria and viruses and get spread easily via person to person but not that much risky for health if get treated properly. A rare but risky conjunctivitis can transmit because of Gonorrhea via bacteria. In adults, Chlamydia can cause this disease. The main reasons behind the disease are bacteria or viruses, fungi, amoebas, parasites, shampoos, dirt, smoke, pool chlorine and some allergic reaction causing factors pollen grains can also transfer conjunctivitis. Some common types of conjunctivitis are viral strains that are most contagious and common, lead to teary eyes and watery discharge.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=141561&RequestType=Sample
Global Conjunctivitis Drugs Market report is segmented on the basis of type, drug class, route of administration, end-user and regional & country level. Based upon type, conjunctivitis drugs market is segmented into viral, bacterial, allergic and others. Based on drug class, conjunctivitis drugs market is segmented into antibiotics, mast cell stabilizers, steroids, and others. Based on route of administration, the market is classified into topical, oral, and intra-vitreal. Based upon end-user, conjunctivitis drugs market is segmented into hospitals and self-administered.
The regions covered in this Conjunctivitis Drugs Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of Conjunctivitis Drugs is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Key Players for Conjunctivitis Drugs Market Report–
Some major key players for Conjunctivitis Drugs market are Akorn Pharmaceuticals, Alcon/ Novartis AG, Allergan Plc, Bausch & Lomb, Valeant Pharmaceuticals, Merck & Co. Inc., Actavis Plc., Pfizer Inc. and others.
Ocular Therapeutix Dosed First Patients in Pivotal Allergic Conjunctivitis Trial of Dextenza.
On 25th September, 2019; Ocular Therapeutix announced that it has dosed first patients in its phase 3 clinical trial of DEXTENZA for the allergic conjunctivitis. Allergic conjunctivitis causes inflammation of the conjunctiva occurred due to an allergic reaction caused by airborne allergens which affects around 70 million people in US concluding itching and burning of the eyes. DEXTENZA has the capacity to interchange the current standard of eye drops with long acting, one time, and seasonal therapy for the allergic conjunctivitis. FDA (Food and Drug Administration) has approved DEXTENZA for the treatment of ocular inflammation and pain leads to ophthalmic surgery. A single DEXTENZA produces 0.4mg dose of dexamethasone for around 30 days followed by insertion. It is inserted into canaliculus by the doctor followed by the surgery. DEXTENZA is free of preservative, resorbable, and not required removal.
Global Conjunctivitis Drugs Market Dynamics –
Around 5 million cases of bacterial conjunctivitis registered every year. Initiatives are taken by the healthcare institutions to spread awareness among people for the treatment of conjunctivitis in developing and underdeveloped countries increases the demand for conjunctivitis drugs and fosters the market growth. The health conditions of the developing and underdeveloped countries are poor and have lack of awareness which leads to the infectious diseases. Also, the rising focus of healthcare sector on eye care reciprocating in a positive way. The rise in healthcare expenditure and the contagious/ spreading characteristic of the disease are strongly supplement the growth of the drugs market. However, the process of drug making for conjunctivitis is very complicated which may hamper the market growth. Moreover, for viral conjunctivitis no drug is available currently. Powerful investments of pharmaceutical companies and vigorous channels with various drugs in the development process are anticipated to give sufficient growth of the market in upcoming period. Huge investments are running on R&D activeness that are deposited to push the market forward.
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=141561&RequestType=Methodology
Global Conjunctivitis Drugs Market Regional Analysis-
Global conjunctivitis drugs market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle east & Africa. North America is anticipated to dominate the global conjunctivitis drugs market owing to the running clinical trials and accessibility & amplified applications of diagnostic test. North America holds the largest share followed by Europe due to their saturated and stagnant nature. About 1% of all primary care office stopovers in US are connected to conjunctivitis which affects nearly 6 million people every year. In Europe, huge patient pool diagnosed with viral conjunctivitis is supplementing the market growth. For example; As per WHO, around 9700 cases of conjunctivitis were registered in 2017 in Europe with the increase in the number of suspected cases considerably with 1680 and 2270 recorded weekly.
Asia-Pacific region is expected to witness a significant growth in the market especially in the countries like India and China due to the growing population, widespread nature of the conjunctivitis and unmet medical needs. According to NCBI, ocular allergies affect nearly 6% to 30% population in Asia-Pacific region.
Key Benefits for Conjunctivitis Drugs Market Report–
Conjunctivitis Drugs Market report covers in-depth historical and forecast analysis.
Conjunctivitis Drugs Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
Conjunctivitis Drugs Market report helps to identify opportunities in marketplace.
Conjunctivitis Drugs Market report covers extensive analysis of emerging trends and competitive landscape.
Global Conjunctivitis Drugs Market Segmentation:
By Drug Class:
Mast cell stabilizers
By Route of Administration:
By Regional & Country Analysis:
Middle East and Africa
Rest of Middle East and Africa
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global Conjunctivitis Drugs Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Conjunctivitis Drugs Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Conjunctivitis Drugs Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis
2.9.1. Market Attractiveness Analysis by Segmentation
2.9.2. Market Attractiveness Analysis by Region
3. Chapter – Global Conjunctivitis Drugs Market Overview: Quantitative Analysis
3.1. Global Conjunctivitis Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global Conjunctivitis Drugs Market Revenue Market Share (%), 2014- 2025
3.3. Global Conjunctivitis Drugs Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global Conjunctivitis Drugs Market Sales Market Share (%), 2014- 2025
4. Chapter – Global Conjunctivitis Drugs Market Analysis: Segmentation By Type
5. Chapter – Global Conjunctivitis Drugs Market Analysis: Segmentation By Application
6. Chapter – Global Conjunctivitis Drugs Market Analysis: By Manufacturer
6.1. Global Conjunctivitis Drugs Market Revenue (USD Million), by Manufacturer, 2014 – 2025
6.2. Global Conjunctivitis Drugs Market Share (%), by Manufacturer, 2018
6.3. Global Conjunctivitis Drugs Market Sales (Number of Units), by Manufacturer, 2014 – 2025
6.4. Global Conjunctivitis Drugs Market Share (%), by Manufacturer, 2018
6.5. Global Conjunctivitis Drugs Market Price (USD/Unit), by Manufacturer, 2014 – 2025
6.6. Global Conjunctivitis Drugs Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
6.7. Merger & Acquisition
6.8. Collaborations and Partnership
6.9. New Product Launch
About us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at email@example.com